Literature DB >> 2173160

[The technique of stereotactic I125 brachytherapy (permanent implants) of brain tumors in Vienna].

R Hawliczek1, P Grunert, H Ferraz-Leite, F Alesch.   

Abstract

Methods of stereotactic target localisation are used in brachytherapy of brain tumors for many years. Since 1987 eight patients with inoperable astrocytomas grade I to III were treated at the Neurosurgical Clinic and Clinic for Radiotherapy of the University Vienna by permanent stereotactic I125-seed implantation. For that purpose a newly developed applicator was used. Preliminary results confine the low risk of operation, but the follow-up time is too short for evaluation of the treatment success. Principal problems of brain brachytherapy are discussed in the light of international data. In general, I125 brachytherapy is a useful and well tolerated way of treatment of low grade astrocytomas, the risk is low, which is especially important for children and old patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173160

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  2 in total

1.  125I inhibited the NSCLC both in vivo and in vitro.

Authors:  Weiliang Yan; Xiaodong Huo; Huixing Wang; Bin Huo; Yongtao Guo; Hua Dong; Guangjun Zheng; Junjie Wang; Shude Chai; Haitao Wang; Zuncheng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

2.  Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.

Authors:  M A Pons; J L Finlay; R W Walker; D Puccetti; R J Packer; M McElwain
Journal:  J Neurooncol       Date:  1992-10       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.